Enliven Therapeutics Earnings
NASDAQ: ELVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
40.98+0.35 (+0.86%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Enliven Therapeutics earnings summary
In its most recent report on Aug 5, 2026 (Q2 2026), ELVN posted EPS of $-0.49. Across the last 16 reports, ELVN shares moved an average of 6.3% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
ELVN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.49 | — | -2.7% |
| May 7, 2026 | — | $-0.38 | — | +1.4% |
| Mar 3, 2026 | — | $-0.45 | — | -5.7% |
| Nov 12, 2025 | — | $-0.32 | — | -1.4% |
| Aug 13, 2025 | — | $-0.49 | — | +3.1% |
| May 14, 2025 | — | $-0.57 | — | -2.7% |
| Mar 13, 2025 | — | $-0.46 | — | +1.6% |
| Nov 13, 2024 | — | $-0.48 | — | +0.5% |
| Aug 13, 2024 | — | $-0.41 | — | -3.0% |
| May 14, 2024 | — | $-0.54 | — | +3.9% |
| Mar 14, 2024 | — | $-0.29 | — | +54.4% |
| Nov 9, 2023 | — | $-0.51 | — | -8.6% |
| Aug 10, 2023 | — | $-0.41 | — | -6.8% |
| May 11, 2023 | — | $-0.80 | — | +4.1% |
| Feb 10, 2023 | — | $-2.91 | — | -0.2% |
| Oct 25, 2022 | — | $-3.27 | — | +0.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.